Algeta ASA We are a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. These alpha-pharmaceuticals harness the unique characteristics of alpha-particle emitters, and offer the potential to deliver potent and localized destruction of cancer cells with minimal effect on surrounding normal cells and a favorable side-effect profile.